Related Experiment Video
Updated: May 20, 2026
07:36
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
Monoclonal antibody dose determination and biodistribution into solid tumors
Robert A Beckman1, Reinhard von Roemeling, Andrew M Scott
1Oncology Clinical Research, Daiichi Sankyo Pharmaceutical Development, 399 Thornall Street, Edison, NJ 08837, USA. eniacl@snip.net
Therapeutic Delivery
|July 27, 2012
Summary
Monoclonal antibody cancer therapy shows promise but faces challenges with deep tumor penetration. Optimizing antibody dosing is crucial to overcome limitations and improve patient survival rates.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Monoclonal antibodies (mAbs) are effective cancer therapeutics with specific targeting and manageable side effects.
- While mAbs can induce tumor shrinkage and improve survival, their large size hinders deep tumor penetration, leading to potential therapeutic escape and relapse.
Purpose of the Study:
- To discuss the challenges of suboptimal dosing in monoclonal antibody cancer therapy.
- To review current methods for determining optimal monoclonal antibody dosage.
- To explore future directions for improving antibody dosing strategies.
Main Methods:
- Review of existing methods for monoclonal antibody dose determination.
- Analysis of limitations associated with current dosing strategies.
- Discussion of potential future research directions.
Main Results:
- Current dosing methods for monoclonal antibodies have limitations.
- Inhomogeneous antibody penetration in tumors can lead to treatment failure.
- Optimal dosing is critical for maximizing the efficacy of monoclonal antibody therapy.
Conclusions:
- Optimizing monoclonal antibody dosing is essential to overcome penetration challenges and improve cancer treatment outcomes.
- Further research into novel dosing strategies is needed to fully realize the potential of antibody therapeutics.
More Related Videos
Related Concept Videos
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...